Development Of Severe Anemia halted The Clinical Trail of Bevacizumab And Sunitinib Malate
Wednesday, July 16th, 2008According to Food and Drug Administration (FDA) several studies on Bevacizumab (Avastin,Genetech,Inc) plus Sunitinib Malate (Sutent, Pfizer, Inc) have been halted due to the reports of Microangiopathic hemolytic anemia (MAHA).
































